Cancer lab firm names Dave Daly to its board

Cancer-focused genetic testing services firm NeoGenomics, based in Fort Myers, Fla., has named Singular Genomics President and COO Dave Daly to its board, according to a Nov. 14 Business Observer report.

Prior to joining Singular Genomics, Daly was CEO at cancer screening company Thrive Earlier Detection, which was acquired by Exact Sciences Corporation for $2.15 billion earlier this year.

Daly's appointment to the board took effect on Nov. 10, according to the report.

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars